Search

Your search keyword '"Chiocca E"' showing total 69 results

Search Constraints

Start Over You searched for: Author "Chiocca E" Remove constraint Author: "Chiocca E" Publisher springer science and business media llc Remove constraint Publisher: springer science and business media llc
69 results on '"Chiocca E"'

Search Results

1. Clinical trial links oncolytic immunoactivation to survival in glioblastoma

2. Specific targeting of glioblastoma with an oncolytic virus expressing a cetuximab-CCL5 fusion protein via innate and adaptive immunity

3. Variants of the adeno-associated virus serotype 9 with enhanced penetration of the blood–brain barrier in rodents and primates

5. Target receptor identification and subsequent treatment of resected brain tumors with encapsulated and engineered allogeneic stem cells

8. An oncolytic virus expressing a full-length antibody enhances antitumor innate immune response to glioblastoma

10. Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial

12. Mechanisms and therapeutic implications of hypermutation in gliomas

13. KLF4K409Q–mutated meningiomas show enhanced hypoxia signaling and respond to mTORC1 inhibitor treatment

14. Glioblastoma infiltration of both tumor- and virus-antigen specific cytotoxic T cells correlates with experimental virotherapy responses

16. The functional synergism of microRNA clustering provides therapeutically relevant epigenetic interference in glioblastoma

17. Correction: Amendments: Publisher Correction: An oncolytic herpesvirus expressing E-cadherin improves survival in mouse models of glioblastoma

18. Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial

19. An oncolytic herpesvirus expressing E-cadherin improves survival in mouse models of glioblastoma

23. Salvage re-irradiation for recurrent high-grade glioma and comparison to bevacizumab alone

29. In vitro screening of clinical drugs identifies sensitizers of oncolytic viral therapy in glioblastoma stem-like cells

30. CAR-Engineered NK Cells Targeting Wild-Type EGFR and EGFRvIII Enhance Killing of Glioblastoma and Patient-Derived Glioblastoma Stem Cells

31. Incidence, risk factors, and reasons for hospitalization among glioblastoma patients receiving chemoradiation

33. Annexin A2 regulates angiogenesis and invasion phenotypes of malignant glioma

38. NK cells impede glioblastoma virotherapy through NKp30 and NKp46 natural cytotoxicity receptors

40. Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR-320

48. GNOSIS: Guidelines for Neuro-Oncology: Standards for Investigational Studies — reporting of surgically based therapeutic clinical trials

Catalog

Books, media, physical & digital resources